Daniela Massi

ORCID: 0000-0002-5688-5923
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cutaneous Melanoma Detection and Management
  • Melanoma and MAPK Pathways
  • Nonmelanoma Skin Cancer Studies
  • Cutaneous lymphoproliferative disorders research
  • Immunotherapy and Immune Responses
  • Cancer and Skin Lesions
  • Optical Coherence Tomography Applications
  • melanin and skin pigmentation
  • CAR-T cell therapy research
  • Cancer Genomics and Diagnostics
  • Cancer Immunotherapy and Biomarkers
  • Genetic and rare skin diseases.
  • Autoimmune Bullous Skin Diseases
  • Advanced Fluorescence Microscopy Techniques
  • Ocular Oncology and Treatments
  • Sarcoma Diagnosis and Treatment
  • Vascular Tumors and Angiosarcomas
  • Nail Diseases and Treatments
  • Cell Image Analysis Techniques
  • Skin Protection and Aging
  • Infectious Diseases and Mycology
  • Dermatologic Treatments and Research
  • Ear and Head Tumors
  • Spectroscopy Techniques in Biomedical and Chemical Research
  • Tumors and Oncological Cases

University of Florence
2016-2025

New York University
2024

Department of Medical Sciences
2024

European Organisation for Research and Treatment of Cancer
2023-2024

Mater Adult Hospital
2024

Azienda Ospedaliero-Universitaria Careggi
2009-2023

European Organisation for Research and Treatment of Cancer
2023

National Research Council
2019-2022

Institute for Marine Biological Resources and Biotechnology
2022

Pathological Society
2013-2021

Purpose The prevalence of BRAF, NRAS, and p16CDKN2A mutations during melanoma progression remains inconclusive. We investigated the distribution in these genes different tissues. Patients Methods In all, 291 tumor tissues from 132 patients with were screened. Paired samples primary melanomas (n = 102) synchronous or asynchronous metastases same 165) included. Tissue underwent mutation analysis (automated DNA sequencing). Secondary lesions included lymph nodes 84), skin 36), visceral 25),...

10.1200/jco.2011.41.2452 article EN Journal of Clinical Oncology 2012-05-22

Cigarette smoke (CS) inhalation causes an early inflammatory response in rodent airways by stimulating capsaicin-sensitive sensory neurons that express transient receptor potential cation channel, subfamily V, member 1 (TRPV1) through unknown mechanism does not involve TRPV1. We hypothesized 2 alpha,beta-unsaturated aldehydes present CS, crotonaldehyde and acrolein, induce neurogenic inflammation TRPA1, excitatory ion channel coexpressed with TRPV1 on nociceptors. found CS aqueous extract...

10.1172/jci34886 article EN Journal of Clinical Investigation 2008-06-01

Cutaneous lymphomas expressing a cytotoxic or natural killer (NK) cell phenotype represent group of lymphoproliferative disorders for which there is currently much confusion and little consensus regarding the best nomenclature classification.This study analyzes 48 cases primary cutaneous lymphoma proteins and/or NK marker, CD56. These were collected workshop European Organization Research Treatment Cancer Lymphoma Task Force, to better clarify clinical, morphologic, phenotypic features these...

10.1002/cncr.11107 article EN Cancer 2003-01-17

Purpose Primary care physicians (PCPs) constitute an appropriate target for new interventions and educational campaigns designed to increase skin cancer screening prevention. The aim of this randomized study was determine whether the adjunct dermoscopy standard clinical examination improves accuracy PCPs triage lesions suggestive cancer. Patients Methods in Barcelona, Spain, Naples, Italy, were given a 1-day training course detection dermoscopic evaluation, randomly assigned evaluation arm...

10.1200/jco.2005.05.0864 article EN Journal of Clinical Oncology 2006-04-18

Background Because of the many limitations studies based on diagnostic setting excised lesions, impact dermoscopy (epiluminescence microscopy, dermatoscopy) in melanoma screening during practice remains to be established. Objectives We assumed that effects use some indicators performance should traceable retrospectively; therefore, we analysed routine malignant/benign ratio melanocytic lesions. Methods Preoperative and histological diagnosis 3053 lesions [319 melanomas (10·4%)] consecutively...

10.1111/j.0007-0963.2004.05860.x article EN British Journal of Dermatology 2004-04-01

We have used nonlinear imaging to evaluate collagen organization in connective tissue ex-vivo samples. Image analysis methods were tested on healthy dermis, normal scars, and keloids. The evaluation of the second harmonic autofluorescence aging index dermis (SAAID) has allowed a first characterization tissues by scoring collagen/elastin content. Further analyses morphology keloids performed image-pattern SHG images. gray-level co-occurrence matrix (GLCM) method classification different based...

10.1002/jbio.200910062 article EN Journal of Biophotonics 2009-09-21

PD-L1 is expressed by a subset of patients with metastatic melanoma (MM) an unfavorable outcome. Its expression increased in cells resistant to BRAF or MEK inhibitors (BRAFi MEKi). However, the function and regulation remain incompletely understood.After generating BRAFi- MEKi-resistant cell lines, we observed marked up-regulation expression. These were characterized common gene profile genes involved movement. Consistently, vitro they showed significantly invasive properties. This phenotype...

10.18632/oncotarget.15213 article EN Oncotarget 2017-02-09

Resistance to anti-PD1-based immune checkpoint blockade (ICB) remains a problem for the treatment of metastatic melanoma. Tumor cells as well host myeloid can express ligand CD155 regulate cell function. However, effect tumor on context human melanoma has not been described. This observational study characterizes expression by tumors and correlates results with differences in features response ICB.Pretreatment specimens, from 155 patients treated ICB 50 BRAF/MEK-directed targeted therapy,...

10.1158/1078-0432.ccr-19-3925 article EN Clinical Cancer Research 2020-04-28

Importance A standardized pathology classification system for melanocytic lesions is needed to aid both pathologists and clinicians in cataloging currently existing diverse terminologies the diagnosis treatment of patients. The Melanocytic Pathology Assessment Tool Hierarchy Diagnosis (MPATH-Dx) has been developed this purpose. Objective To revise MPATH-Dx version 1.0 tool, using feedback from dermatopathologists participating National Institutes Health–funded Reducing Errors Interpretations...

10.1001/jamanetworkopen.2022.50613 article EN cc-by-nc-nd JAMA Network Open 2023-01-11
Coming Soon ...